Your SlideShare is downloading. ×
Vaccines 2011: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
Vaccines 2011: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
Vaccines 2011: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
Vaccines 2011: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
Vaccines 2011: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
Vaccines 2011: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
Vaccines 2011: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
Vaccines 2011: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
Vaccines 2011: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
Vaccines 2011: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
Vaccines 2011: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Vaccines 2011: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry

1,816

Published on

Kalorama Information has been closely following vaccine markets and since 2003 has instituted a yearly market research report schedule to keep up with fast-moving developments. Our latest …

Kalorama Information has been closely following vaccine markets and since 2003 has instituted a yearly market research report schedule to keep up with fast-moving developments. Our latest comprehensive update, Vaccines 2011: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry, examines the market for vaccines used in humans for various disease. This state-of-the-industry report is a must-have for any executive who wants to stay on top of a rapidly changing market and see what’s expected based on analysis of major company pipelines.

Published in: Health & Medicine, Business
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
1,816
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
48
Comments
0
Likes
1
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Vaccines 2011: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing IndustryPublished: July 2011No. of Pages: 180Price: $ 4200The high growth rates and successful launch of several products recently has kept interestin the global vaccine market high. The global market for vaccines experienced stronggrowth through 2010 and this is expected to continue through the forecast period. Growth isbeing fueled by new product introductions and rising usage in all regions.Kalorama Information has been closely following vaccines market and since 2003 hasinstituted a yearly market research report schedule to keep up with fast-movingdevelopments. Our latest comprehensive update, Vaccines 2011: World Market Analysis,Key Players, and Critical Trends in a Fast-Changing Industry, examines the market forvaccines used in humans for various disease. This state-of-the-industry report is a must-have for any executive who wants to stay on top of a rapidly changing market and seewhat’s expected based on analysis of major company pipelines.You can also browse reports related to Pharmaceuticals Market ResearchTrends are discussed in this report including the introduction of needle-free systems and theproduction of vaccines, as well as product safety, supply shortages, and the use of vaccinesto prevent pandemics and address bioterrorism, and innovations in vaccine deliverysystems. News and reports of vaccine-related illness tend to exacerbate the public’s fearsand result in higher rates of non-immunization, and these are discussed in this edition ofthe report.The report covers only commercialized vaccines and developmental vaccines for diseasesthat are already vaccine-preventable; it does not cover emerging vaccines for diseases thatare not currently vaccine-preventable.Included in this report are current market size and forecast for the following vaccines:Pediatric Vaccines:
  • 2. • Combinations• Hepatitis• HIB• MMR• Pneumococcal• Poliovirus• Varicella• Other PediatricAdult Vaccines:• Cervical Cancer• Hepatitis• Influenza• Pneumococcal• Travel; DT; Misc.Important trends such as vaccine safety, vaccine shortages, preventing pandemics, vaccinesand bioterrorism, DNA vaccination, innovations in vaccine delivery systems and innovationsin vaccine Production are covered in the report.Kalorama has expanded the global perspective of this report in this edition, includingestimates of vaccine sales (pediatric and adult segments) in the following regions:• U.S.• Rest of North Amer.• South America• Europe• Japan• India• China• Rest of WorldIn addition, the report profiles key competitors in the vaccine industry. Companies profiledin the report include:• AlphaVax, Inc.• Bavarian Nordic A/S• Baxter Healthcare• Bharat Biotech• Celldex Therapeutics• Crucell / Johnson and Johnson• Emergent biosolutions• GlaxoSmithKline• Medimmune• Merck & Co. Inc• Nabi Biopharmaceuticals• Novartis
  • 3. • Pfizer• Sanofi PasteurRevenue estimates for each market segment represent global revenues and are expressedin current dollars. Estimates are provided for the historic 2005 to 2009 period and forecastsare provided through 2014. Historical information for this report was gathered from a widevariety of published sources including company reports and filings, government documents,legal filings, trade journals, newspapers and business press, analysts’ reports and othersources. Interviews with company representatives and other experts were conducted tocapture the perspectives from industry participants’ point of view and assess trends... theseform the basis of the forecasting and competitive analysis.TABLE OF CONTENTSEXECUTIVE SUMMARYTHE GLOBAL VACCINES INDUSTRYScope and MethodologyOverviewPediatric Preventative VaccinesThe MarketThe MarketTotal MarketIssues and TrendsCHAPTER TWO: INTRODUCTION TO VACCINESA Brief History: The Development of VaccinesThe Immune ResponseMechanism of ActionTypes of VaccinesAttenuated (Weakened) Live VirusesKilled (Inactivated) VirusesToxoid VaccinesGenetically Engineered/Modified VaccinesSubunit VaccinesConjugate VaccinesDNA VaccinationVaccine Approval ProcessCHAPTER THREE: PEDIATRIC PREVENTIVE VACCINESIntroductionChildhood Immunization in the United StatesChildhood Immunization RatesChallenges to the Vaccine Delivery System
  • 4. The Effect of U.S. Healthcare ReformRecommended Childhood Immunization ScheduleState Immunization RecommendationsUnited Nations InitiativesPediatric Vaccine ProductsBCGDiphtheria, Tetanus, Pertussis, Hepatitis B and PolioDiphtheriaPertussisTetanusHepatitis BPoliomyelitisEnterotoxigenic Escherichia coliHaemophilus Influenzae Type BHepatitis AMeasles, Mumps and RubellaMeaslesMumpsRubellaMeningococcal DiseaseParainfluenza Virus Type 3Pneumococcal ConjugateRotavirusRespiratory Syncytial VirusVaricellaPediatric Vaccines in DevelopmentCost of Vaccines in the United StatesThe World Market for Pediatric Preventive VaccinesTotal Market Size and ForecastHepatitis Vaccine MarketMarket AnalysisLeading Products and CompetitorsHaemophilus Influenzae Type B Vaccine MarketMarket AnalysisLeading Products and CompetitorsMeasles, Mumps and Rubella VaccinesMarket AnalysisCombination Vaccines MarketMarket AnalysisLeading Products and CompetitorsPneumococcal VaccineLeading Products and CompetitorsPoliovirus VaccineMarket Analysis
  • 5. Leading Products and CompetitorsVaricella VaccinesMarket AnalysisLeading Products and CompetitorsOther Vaccines MarketMarket AnalysisLeading Products and CompetitorsCHAPTER FOUR: ADULT PREVENTIVE VACCINESIntroductionAdult Vaccine-Preventable Diseases: Facts and FiguresGlobal Influenza Surveillance ProgramU.S. SurveillanceRecommendations for Adult ImmunizationsWHO International Health RegulationsAdult Vaccine ProductsAllergiesCervical CancerCholeraDengue FeverDiphtheria-TetanusHepatitisHepatitis AHepatitis BInfluenzaJapanese EncephalitisMalariaPneumococcal DiseaseRabiesShinglesTyphoid FeverYellow FeverAdult Vaccines in DevelopmentTotal Market Size and ForecastCervical Cancer MarketMarket AnalysisLeading Products and CompetitorsHepatitis MarketMarket AnalysisLeading Products and CompetitorsInfluenza Vaccine MarketMarket AnalysisLeading Products and CompetitorsMarket Analysis
  • 6. Leading Products and CompetitorsTravel, DT, and Miscellaneous Vaccine MarketMarket AnalysisLeading Products and CompetitorsCHAPTER FIVE: VACCINES MARKET SUMMARYTrends Driving the Vaccines MarketMarket Size and ForecastVaccine Sales by RegionVaccine Market CompetitorsPediatric VaccinesMajor Manufacturers’ Market ShareAdult VaccinesMajor Manufacturers’ Market ShareCHAPTER SIX: ISSUES AND TRENDSVaccine SafetyRefusal to ImmunizeObesityPost-Licensure SurveillanceVaccine Adverse Event Reporting SystemThe Vaccine Safety Datalink ProjectPhase IV studiesThe Vaccine Injury Compensation ProgramCountermeasures Injury Compensation ProgramWorld Health OrganizationOther InitiativesThe Future of Vaccine SafetyVaccine ShortagesPreventing Shortages in the Developed CountriesFinancial incentivesEquitable pricingVaccine stockpilesPreventing Shortages in Developing NationsVaccine bondsPreventing PandemicsU.S. National Vaccine PlanVaccines and BioterrorismOverviewProject Bioshield ActNational Bio and Agro-Defense FacilityVaccine Treatment and Evaluation UnitsAnthraxSmallpox
  • 7. TularemiaViral Hemorrhagic FeversDTC Advertising of VaccinesDNA VaccinationInnovations in Vaccine Delivery SystemsEdible VaccinesMucosal DeliveryIntranasal DeliveryVaccine PatchesVaccine ChipsInnovations in Vaccine ProductionTobacco PlantsInsectsNanoparticle SystemsCloningCHAPTER SEVEN: COMPANY PROFILESAlphaVax, Inc.History and Lines of BusinessStrategic AlliancesVaccine ProductsFinancial InformationBavarian Nordic A/SHistory and Lines of BusinessStrategic AlliancesVaccine ProductsFinancial InformationBaxter HealthcareHistory and Lines of BusinessStrategic AlliancesVaccine ProductsFinancial InformationBharat BiotechHistory and Lines of BusinessStrategic AlliancesVaccine ProductsFinancial InformationCelldex TherapeuticsHistory and Lines of BusinessStrategic AlliancesVaccine ProductsFinancial InformationCrucell /Johnson & JohnsonHistory and Lines of Business
  • 8. Strategic AlliancesVaccine ProductsFinancial InformationEmergent biosolutionsHistory and Lines of Business Strategic Acquisition and AllianceVaccine ProductsFinancialGlaxoSmithKlineHistory and Lines of BusinessStrategic AlliancesVaccine ProductsFinancial InformationMedimmuneHistory and Lines of BusinessStrategic AlliancesVaccine ProductsFinancial InformationMerck & Co. IncHistory and Lines of BusinessStrategic AlliancesVaccine ProductsFinancial InformationNabi BiopharmaceuticalsHistory and Lines of Business Strategic AllianceVaccine ProductsFinancial InformationNovartisHistory and Lines of BusinessStrategic AlliancesVaccine ProductsFinancial Information History and Lines of BusinessStrategic AlliancesVaccine ProductsFinancial InformationSanofi PasteurHistory and Lines of BusinessStrategic AlliancesVaccine ProductsFinancial InformationCOMPANY DIRECTORYLIST OF EXHIBITS
  • 9. CHAPTER ONE: EXECUTIVE SUMMARYFigure 1-1: World Market for Pediatric Vaccines 2005-2014 RevenuesFigure 1-2: World Market for Adult Vaccines 2005-2014 RevenuesCHAPTER TWO: INTRODUCTION TO VACCINESTable 2-1: Impact of Vaccines in the 20th Century Annual Morbidity in the 20th Century vs2010Figure 2-1: Attenuated Virus ProductionTable 2-2: Vaccine-Preventable Diseases, June 2011Table 2-3: VAERS Table of Reportable Events Following VaccinationCHAPTER THREE: PEDIATRIC PREVENTIVE VACCINESTable 3-1: Global Immunization Rates by Vaccine Type (DPT3, BCG, HepB, Yellow Fever,Tetanus, Hib, MCV, Polio) 2009Table 3-2: Immunization Profile of the United States: Population by Age Group, Number ofVaccine-Preventable Diseases Reported by Disease 1990 - 2009Table 3-3: U.S. Recommended Immunization Schedule for Children Ages 0 Through 6 Years,2011Table 3-4: U.S. Recommended Immunization Schedule for Adolescents Ages 7 to 18 Years,2011Table 3-5: Selected Pediatric Vaccines in Development, June 2011Table 3-6: World Market for Pediatric Vaccines, 2006-2015..Figure 3-1: Market Share of Pediatric Vaccines by Type 2010Figure 3-2: Market Share of Pediatric Vaccines, by Type 2015Table 3-7: World Market for Pediatric Vaccines by Region (U.S., Rest of North America,South America, EU, Japan, India, China, Rest of World) 2006-2015 RevenuesTable 3-8: World Pediatric Hepatitis Vaccine Market 2006-2015Table 3-9: World Hib Vaccine Market, 2006-2015Table 3-10: World MMR Vaccines Market 2006-2015Table 3-11: World Combination Vaccines Market 2006-2015Table 3-12: World Pediatric Pneumococcal Vaccine Market 2006-2015Table 3-13: World Poliovirus Vaccine Market 2006-2015Table 3-14: World Varicella Vaccine Market 2006-2015Table 3-15: World Pediatric Other Vaccines Market 2006-2015CHAPTER FOUR: ADULT PREVENTIVE VACCINESTable 4-1: Universal Adult Immunization Schedule 2011Table 4-2: Adult Immunization Schedule for Populations with Special Medical Conditions,2011Table 4-3: Initiatives to Require HPV Vaccination by U.S. State, 2011Table 4-4: WHO Pandemic Classification ScheduleTable 4-5: Selected Adult Preventive Vaccines in Development, 2011Table 4-6: World Market for Adult Preventive Vaccines, 2006-2015Figure 4-1: Market Share of Adult Vaccines, by Type, 2010Figure 4-2: Market Share of Adult Vaccines, by Type, 2015
  • 10. Table 4-7: World Market for Adult Vaccines by Region (U.S., Rest pf North Amer., SouthAmerica, EU, Japan, India, China, Rest of World) 2006-2015Table 4-8: World Cervical CancerVaccine Market 2006-2015Table 4-9: World Hepatitis Vaccine Market 2006-2015World Influenza Vaccine Market 2006-2015Table 4-11: 2010 Estimated Population by Region (Africa, Asia, Europe, N. America,Oceania, South America) and Selected Age Group (in millions)Table 4-12: World Pneumococcal Vaccine Market 2006-2015World Travel; Diphtheria-Tetanus; Miscellaneous Vaccines Market 2006-2015CHAPTER FIVE: VACCINES MARKET SUMMARYFigure 5-1: Sales Growth of Vaccines vs. Pharmaceuticals 2006-2015Figure 5-2: World Market for Vaccines by Type 2006-2015Table 5-1: The World Vaccines Market by Vaccine Type 2006-2015Figure 5-3: World Market for Vaccines Share by Type (Pediatric, Adult), 2006, 2010 and2015Table 5-2: The World Vaccines Market by Region (U.S, Rest of North Amer., South America,EU, Japan, India, China, ROW) 2006-2015 Revenues (in millions)Table 5-3: Major Manufacturers’ Shares of the World Vaccine Market, 2010Figure 5-3: 2010 World Vaccines Market Share, by Leading CompetitorsTable 5-4: Major Manufacturer’s Shares of the World Pediatric Vaccine Market 2010Figure 5-5: Market Share of Pediatric Vaccines Market, 2010Table 5-5: Major Manufacturer’s Shares of the World Adult Vaccine Market 2010Figure 5-6: Market Share of Adult Vaccines Market 2010CHAPTER SIX: ISSUES AND TRENDSTable 7-1: Selected Companies/Laboratories Developing Biodefense VaccinesAbout Us:ReportsnReports is an online library of over 100,000+ market research reports and in-depthmarket research studies & analysis of over 5000 micro markets. We provide 24/7 online andoffline support to our customers. Get in touch with us for your needs of market researchreports.Follow us on Twitter: http://twitter.com/marketsreportsOur Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689Contact:Mr.Priyank7557 Rambler road,Suite727,Dallas,TX75231Tel: +1-888-989-8004E-mail: sales@reportsnreports.com
  • 11. http://www.reportsnreports.comVisit our Market Research Blog

×